Issues of concern

The graph below shows the percentage of the fund invested in each of the worst issues of concern to New Zealanders. Below the graph are listed all the companies this fund invests in, by issue of concern.


  • Human Rights Violations
  • Environmental Harm
  • Animal Cruelty
  • Weapons
  • Fossil Fuels
  • Social Harm

Companies of concern

    • Thermo Fisher Scientific Inc 1.23%
    • Dottikon Es Holding AG-Reg 0.16%

This data is compiled by Mindful Money from the fund information and portfolios that each fund has filed with the Disclose register to 31st March 2023 and Mindful Money analysis of funds within those portfolios. The list of companies of concern has been drawn from ratings agencies and public sources, including the Norwegian Sovereign Fund, NZ Super Fund, Sustainalytics and research organisations.

Please note that companies may breach more than one of these areas of concern.

The listing of companies of concern is based on definitions used in Mindful Money's methodology. These definitions may be different from the exclusions policy and definitions applied by the fund provider.

Mindful Money uses the term Mindful Funds as our standard for ethical investment and responsible investment. This does not imply that other funds are unethical or that the fund providers that do not meet these standards are unethical providers.

About this fund

Invests in international shares and is designed to track the return (before tax, fees and other expenses) of the iSTOXX(r) FactSet Breakthrough Healthcare Index.

Value $28M NZD
Period of data report 30th June 2023
Fund started 6th June 2019
Total annual fund fees 0.75%
Total performance based fees 0.0%
Manager's basic fee 0.72%
Other management and administration charges 0.03%
Total other charges 0.0
Total other charges currency NZD

Guy Roulston Elliffe

Currently: Director (7 years, 7 months)
Previously: Corporate Governance Manager - ACC (current position) (8 years, 2 months)

Stuart Kenneth Reginald Millar

Currently: Chief Investment Officer - Smartshares (4 years, 1 months)
Previously: Head of Portfolio Management - ANZ Investments (6 years, 4 months)

Graham Nicholas Stewart Law

Currently: Director (1 years, 6 months)
Previously: Chief Financial and Corporate Officer - NZX (current position) (5 years, 6 months)

Alister John Williams

Currently: Director (7 years, 7 months)
Previously: Investment Manager - Trust Management (5 years, 4 months)

This information has been sourced from the quarterly data that each fund has filed with Disclose register to 30th June 2023.

Past Returns

Past annual returns for this fund are after fees and taxes. Please note that higher past returns do not always mean higher future returns.

Year Market Average Fund Annual Return
2023 -5.17% -5.9%
2022 3.53% -13.33%
2021 35.55% 38.36%

The market average is the average return for funds of the same risk category, sourced from the Commission for Financial Capability's Sorted website. The fund information has been sourced from the quarterly data that each fund has filed with Disclose register to 30th June 2023.

Top 10 Investments

  • Ishares Healthcare Innovation Ucits ETF
    Ireland International Equities
  • ANZ NZD Current Account
    New Zealand Cash and Equivalents AA-
Type Target Actual
Cash and Cash Equivalents 0.0% 0.092415%
New Zealand Fixed Interest 0.0% 0.0%
International Fixed Interest 0.0% 0.0%
Australasian Equities 0.0% 0.0%
International Equities 100.0% 99.90759%
Listed Properties 0.0% 0.0%
Unlisted Properties 0.0% 0.0%
Other 0.0% 0.0%
Commodities 0.0% 0.0%

Investment Mix

How the money in this fund is invested against the fund's targets.

This information has been sourced from the quarterly data that each fund has filed with Disclose register to 30th June 2023.